{"L1":{"drugs":[{"name":"paclitaxel","moa":"taxane chemotherapy","efficacy_score":0.32,"confidence":0.6,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["CONFIDENCE_CAP_L1","SPORADIC_SUMMARY"],"efficacy_delta":0.0,"confidence_delta":-0.07000000000000006,"rationale":[{"gate":"CONFIDENCE_CAP_L1","verdict":"CAPPED","cap":0.6,"level":"L1","completeness":0.55,"original_confidence":0.67,"capped_confidence":0.6,"reason":"Level 1 data (completeness=0.55) → confidence capped at 0.6"},{"gate":"SPORADIC_SUMMARY","germline_status":"positive","level":"L1","completeness":0.55,"original_efficacy":0.32,"final_efficacy":0.32,"efficacy_delta":0.0,"original_confidence":0.67,"final_confidence":0.6,"confidence_delta":-0.07000000000000006,"gates_applied":["CONFIDENCE_CAP_L1"]}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"adavosertib","moa":"WEE1 inhibitor","efficacy_score":0.32,"confidence":0.6,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["CONFIDENCE_CAP_L1","SPORADIC_SUMMARY"],"efficacy_delta":0.0,"confidence_delta":-0.07000000000000006,"rationale":[{"gate":"CONFIDENCE_CAP_L1","verdict":"CAPPED","cap":0.6,"level":"L1","completeness":0.55,"original_confidence":0.67,"capped_confidence":0.6,"reason":"Level 1 data (completeness=0.55) → confidence capped at 0.6"},{"gate":"SPORADIC_SUMMARY","germline_status":"positive","level":"L1","completeness":0.55,"original_efficacy":0.32,"final_efficacy":0.32,"efficacy_delta":0.0,"original_confidence":0.67,"final_confidence":0.6,"confidence_delta":-0.07000000000000006,"gates_applied":["CONFIDENCE_CAP_L1"]}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"ceralasertib","moa":"ATR inhibitor","efficacy_score":0.12,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L1","completeness":0.55,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 1 data (completeness=0.55) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"trametinib","moa":"MEK inhibitor","efficacy_score":0.12,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L1","completeness":0.55,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 1 data (completeness=0.55) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"bevacizumab","moa":"anti-VEGF","efficacy_score":0.12,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L1","completeness":0.55,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 1 data (completeness=0.55) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"pembrolizumab","moa":"anti-PD-1","efficacy_score":0.12,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":[null,"CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":null,"verdict":"NO_BOOST","boost":1.0,"reason":"No IO boost signals detected","safety_metadata":{},"ruo_disclaimer":null},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L1","completeness":0.55,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 1 data (completeness=0.55) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"olaparib","moa":"PARP inhibitor","efficacy_score":0.12,"confidence":0.43,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L1","completeness":0.55,"original_confidence":0.43,"capped_confidence":0.43,"reason":"Level 1 data (completeness=0.55) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"niraparib","moa":"PARP inhibitor","efficacy_score":0.12,"confidence":0.43,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L1","completeness":0.55,"original_confidence":0.43,"capped_confidence":0.43,"reason":"Level 1 data (completeness=0.55) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"rucaparib","moa":"PARP inhibitor","efficacy_score":0.12,"confidence":0.43,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L1","completeness":0.55,"original_confidence":0.43,"capped_confidence":0.43,"reason":"Level 1 data (completeness=0.55) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"carboplatin","moa":"platinum alkylating agent","efficacy_score":0.12,"confidence":0.43,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L1","gates_applied":["OVARIAN_PATHWAY_GATES","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"OVARIAN_PATHWAY_GATES","verdict":"NO_CHANGE","multiplier":1.0,"reason":"No expression data available for pathway-based prediction. Relying on HRD-based PARP gates (see PARP_GERMLINE/PARP_HRD_RESCUE gates)."},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L1","completeness":0.55,"original_confidence":0.43,"capped_confidence":0.43,"reason":"Level 1 data (completeness=0.55) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"}],"pathway_scores":{"tp53":0.4,"ddr":null,"mapk":null,"pi3k":null,"vegf":null,"her2":null,"io":null,"efflux":null},"pathway_scores_meta":{"normalized":true,"defaulted":true,"defaulted_keys":["ddr","mapk","pi3k","vegf","her2","io","efflux"],"upstream_keys_present":["ddr","efflux","her2","io","mapk","pi3k","tp53","vegf"],"normalization_version":"v1-null-defaults"},"inputs_used":{"mutations":[{"gene":"MBD4","hgvs_p":"p.K431Nfs*54","hgvs_c":"c.1293delA","consequence":"frameshift_variant","classification":"pathogenic","chrom":"3","pos":129433949,"ref":"AT","alt":"A","build":"GRCh38"},{"gene":"PDGFRA","hgvs_p":"p.S755P","hgvs_c":"c.2263T>C","consequence":"missense_variant","classification":"VUS","chrom":"4","pos":54280422,"ref":"T","alt":"C","build":"GRCh38"},{"gene":"TP53","hgvs_p":"p.R175H","hgvs_c":"c.524G>A","consequence":"missense_variant","chrom":"17","pos":7577120,"ref":"G","alt":"A"}],"tumor_context":{"completeness_score":0.55,"somatic_mutations":[{"gene":"TP53","hgvs_p":"p.R175H","consequence":"missense_variant"}],"msi_status":"MSS","pd_l1_status":"POSITIVE","pd_l1_cps":10,"er_status":"WEAKLY_POSITIVE","er_percent":50}},"provenance":{"run_id":"75f5d4e4-df5e-4ed4-bdaa-6b89802aa5ef","profile":"baseline","cache":"miss","flags":{"fusion_active":false,"evo_use_delta_only":true,"evidence_enabled":true,"confidence_v2":false},"sequence_scoring":{"engine_used":"evo2","true_scoring_required":false,"allow_heuristic_sequence":true,"heuristic_used":false,"variants_sent_to_engine":[{"gene":"PDGFRA","chrom":"4","pos":54280422,"ref":"T","alt":"C","build":"GRCh38","consequence":"missense_variant"},{"gene":"TP53","chrom":"17","pos":7577120,"ref":"G","alt":"A","build":null,"consequence":"missense_variant"}],"variants_excluded":[{"variant":{"gene":"MBD4","chrom":"3","pos":129433949,"ref":"AT","alt":"A"},"reason":"non_snv_requires_normalization"}],"mode":"evo2_adaptive","count":2},"primary_variant_selection":{"strategy":"max(calibrated_seq_percentile, sequence_disruption)","primary_gene":"TP53","primary_hgvs_p":"p.R175H"},"insights":"skipped_fast_mode","low_confidence_filter":"skipped_by_request_option","confidence_threshold_applied":0.3,"filtered_count":10,"rejected_count":0,"confidence_breakdown":{"top_drug":"paclitaxel","confidence":0.6,"tier":"insufficient","badges":["PathwayAligned"],"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"S_contribution":0.8,"P_contribution":1.0,"E_contribution":0.0,"pathway_disruption":{"tp53":0.4}},"lifts":{"ablation_mode":"SPE"},"variant_resolution":{"resolved_count":3,"attempted_count":3,"receipts":[{"gene":"MBD4","hgvs":"MBD4:c.1293delA","ok":true,"receipt":{"ok":true,"status":200,"url":"https://rest.ensembl.org/vep/human/hgvs/MBD4%3Ac.1293delA?content-type=application/json","response":{"assembly":"GRCh38","chrom":"3","pos":129433950,"ref":"T","alt":"-","most_severe_consequence":"frameshift_variant","allele_string":"A/-","normalization":{"needs_left_padding_for_deletion":true,"reference_base":"T","strand_complement_applied":true,"original_ref":"A","original_alt":"-"}}}},{"gene":"MBD4","hgvs":"MBD4:c.1293delA","ok":true,"note":"left_pad_deletion","receipt":{"ok":true,"new_variant":{"chrom":"3","pos":129433949,"ref":"AT","alt":"A","assembly":"GRCh38"},"receipt":{"left_base":{"ok":true,"status":200,"url":"https://rest.ensembl.org/sequence/region/human/3:129433949..129433949?coord_system_version=GRCh38","response":{"seq":"A"}}}}},{"gene":"PDGFRA","hgvs":"PDGFRA:c.2263T>C","ok":true,"receipt":{"ok":true,"status":200,"url":"https://rest.ensembl.org/vep/human/hgvs/PDGFRA%3Ac.2263T%3EC?content-type=application/json","response":{"assembly":"GRCh38","chrom":"4","pos":54280422,"ref":"T","alt":"C","most_severe_consequence":"missense_variant","allele_string":"T/C","normalization":{"needs_left_padding_for_deletion":false,"reference_base":"T"}}}}]}},"completeness":{"level":"L1","level_name":"Partial","completeness_score":0.55,"has_germline":true,"has_somatic_ngs":true,"has_ihc":true,"has_hrd":false,"has_tmb":false,"has_expression":false,"has_ca125":false,"missing":["HRD score","TMB score","RNA expression data","CA-125 lab values"],"confidence_cap":0.6}},"L2":{"drugs":[{"name":"olaparib","moa":"PARP inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"niraparib","moa":"PARP inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"rucaparib","moa":"PARP inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"carboplatin","moa":"platinum alkylating agent","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["OVARIAN_PATHWAY_GATES","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"OVARIAN_PATHWAY_GATES","verdict":"NO_CHANGE","multiplier":1.0,"reason":"No expression data available for pathway-based prediction. Relying on HRD-based PARP gates (see PARP_GERMLINE/PARP_HRD_RESCUE gates)."},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"paclitaxel","moa":"taxane chemotherapy","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"adavosertib","moa":"WEE1 inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"ceralasertib","moa":"ATR inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"trametinib","moa":"MEK inhibitor","efficacy_score":0.12,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"bevacizumab","moa":"anti-VEGF","efficacy_score":0.12,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"pembrolizumab","moa":"anti-PD-1","efficacy_score":0.162,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["IO_TMB_BOOST","CONFIDENCE_CAP_L2","SPORADIC_SUMMARY"],"efficacy_delta":0.04200000000000001,"confidence_delta":0.0,"rationale":[{"gate":"IO_TMB_BOOST","verdict":"BOOSTED","boost":1.35,"tmb":25.0,"reason":"TMB-high (≥20): 25.0 mut/Mb → Checkpoint inhibitor boost 1.35x"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.8,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 2 data (completeness=0.80) → no confidence cap applied"},{"gate":"SPORADIC_SUMMARY","germline_status":"positive","level":"L2","completeness":0.8,"original_efficacy":0.12,"final_efficacy":0.162,"efficacy_delta":0.04200000000000001,"original_confidence":0.53,"final_confidence":0.53,"confidence_delta":0.0,"gates_applied":["IO_TMB_BOOST","CONFIDENCE_CAP_L2"]}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"}],"pathway_scores":{"tp53":0.4,"ddr":0.01,"immune":0.003,"mapk":null,"pi3k":null,"vegf":null,"her2":null,"io":null,"efflux":null},"pathway_scores_meta":{"normalized":true,"defaulted":true,"defaulted_keys":["mapk","pi3k","vegf","her2","io","efflux"],"upstream_keys_present":["ddr","efflux","her2","immune","io","mapk","pi3k","tp53","vegf"],"normalization_version":"v1-null-defaults"},"inputs_used":{"mutations":[{"gene":"MBD4","hgvs_p":"p.K431Nfs*54","hgvs_c":"c.1293delA","consequence":"frameshift_variant","classification":"pathogenic","chrom":"3","pos":129433949,"ref":"AT","alt":"A","build":"GRCh38"},{"gene":"PDGFRA","hgvs_p":"p.S755P","hgvs_c":"c.2263T>C","consequence":"missense_variant","classification":"VUS","chrom":"4","pos":54280422,"ref":"T","alt":"C","build":"GRCh38"},{"gene":"TP53","hgvs_p":"p.R273H","hgvs_c":"c.818G>A","consequence":"missense_variant","data_origin":"scenario_inferred","chrom":"17","pos":7673802,"ref":"G","alt":"A"},{"gene":"BRCA1","hgvs_p":"p.E23fs","hgvs_c":"c.68_69delAG","consequence":"frameshift_variant","data_origin":"scenario_inferred","chrom":"17","pos":43044295,"ref":"AG","alt":"-"}],"tumor_context":{"completeness_score":0.8,"somatic_mutations":[{"gene":"TP53","hgvs_p":"p.R273H","consequence":"missense_variant"},{"gene":"BRCA1","hgvs_p":"p.E23fs","consequence":"frameshift_variant"}],"hrd_score":72.0,"hrd_status":"HIGH","tmb":25.0,"tmb_status":"HIGH","msi_status":"MSS","pd_l1_status":"POSITIVE","pd_l1_cps":10,"er_status":"WEAKLY_POSITIVE","er_percent":50,"sig7_exposure":0.12}},"provenance":{"run_id":"684c90f3-05fa-4fa8-9b27-7cdf11c09867","profile":"baseline","cache":"miss","flags":{"fusion_active":false,"evo_use_delta_only":true,"evidence_enabled":true,"confidence_v2":false},"sequence_scoring":{"engine_used":"evo2","true_scoring_required":false,"allow_heuristic_sequence":true,"heuristic_used":false,"variants_sent_to_engine":[{"gene":"PDGFRA","chrom":"4","pos":54280422,"ref":"T","alt":"C","build":"GRCh38","consequence":"missense_variant"},{"gene":"TP53","chrom":"17","pos":7673802,"ref":"G","alt":"A","build":null,"consequence":"missense_variant"}],"variants_excluded":[{"variant":{"gene":"MBD4","chrom":"3","pos":129433949,"ref":"AT","alt":"A"},"reason":"non_snv_requires_normalization"},{"variant":{"gene":"BRCA1","chrom":"17","pos":43044295,"ref":"AG","alt":"-"},"reason":"non_snv_requires_normalization"}],"mode":"evo2_adaptive","count":2},"primary_variant_selection":{"strategy":"max(calibrated_seq_percentile, sequence_disruption)","primary_gene":"TP53","primary_hgvs_p":"p.R273H"},"insights":"skipped_fast_mode","low_confidence_filter":"skipped_by_request_option","confidence_threshold_applied":0.3,"filtered_count":10,"rejected_count":0,"confidence_breakdown":{"top_drug":"olaparib","confidence":0.67,"tier":"insufficient","badges":["PathwayAligned"],"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"S_contribution":0.8,"P_contribution":1.0,"E_contribution":0.0,"pathway_disruption":{"tp53":0.4,"ddr":0.01,"immune":0.003}},"lifts":{"ablation_mode":"SPE"},"variant_resolution":{"resolved_count":3,"attempted_count":3,"receipts":[{"gene":"MBD4","hgvs":"MBD4:c.1293delA","ok":true,"receipt":{"ok":true,"status":200,"url":"https://rest.ensembl.org/vep/human/hgvs/MBD4%3Ac.1293delA?content-type=application/json","response":{"assembly":"GRCh38","chrom":"3","pos":129433950,"ref":"T","alt":"-","most_severe_consequence":"frameshift_variant","allele_string":"A/-","normalization":{"needs_left_padding_for_deletion":true,"reference_base":"T","strand_complement_applied":true,"original_ref":"A","original_alt":"-"}}}},{"gene":"MBD4","hgvs":"MBD4:c.1293delA","ok":true,"note":"left_pad_deletion","receipt":{"ok":true,"new_variant":{"chrom":"3","pos":129433949,"ref":"AT","alt":"A","assembly":"GRCh38"},"receipt":{"left_base":{"ok":true,"status":200,"url":"https://rest.ensembl.org/sequence/region/human/3:129433949..129433949?coord_system_version=GRCh38","response":{"seq":"A"}}}}},{"gene":"PDGFRA","hgvs":"PDGFRA:c.2263T>C","ok":true,"receipt":{"ok":true,"status":200,"url":"https://rest.ensembl.org/vep/human/hgvs/PDGFRA%3Ac.2263T%3EC?content-type=application/json","response":{"assembly":"GRCh38","chrom":"4","pos":54280422,"ref":"T","alt":"C","most_severe_consequence":"missense_variant","allele_string":"T/C","normalization":{"needs_left_padding_for_deletion":false,"reference_base":"T"}}}}]}},"completeness":{"level":"L2","level_name":"Good","completeness_score":0.8,"has_germline":true,"has_somatic_ngs":true,"has_ihc":true,"has_hrd":true,"has_tmb":true,"has_expression":false,"has_ca125":false,"missing":["RNA expression data","CA-125 lab values"],"confidence_cap":null}},"L3":{"drugs":[{"name":"olaparib","moa":"PARP inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"niraparib","moa":"PARP inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"rucaparib","moa":"PARP inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["PARP_GERMLINE","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"PARP_GERMLINE","verdict":"FULL_EFFECT","penalty":1.0,"reason":"Germline BRCA1/2 positive → PARP inhibitor appropriate"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"carboplatin","moa":"platinum alkylating agent","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["OVARIAN_PATHWAY_GATES","CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"OVARIAN_PATHWAY_GATES","verdict":"FALLBACK","multiplier":1.0,"composite_raw":7.785882352941176,"fallback_reason":"Expression data quality insufficient: ['Low gene count (94 < 1000). Pathway prediction may be unreliable.']","ruo_disclaimer":"Research Use Only (RUO): Ovarian cancer pathway-based resistance prediction is validated on GSE165897 (n=11 HGSOC patients, AUC=0.750). This prediction is for research purposes only and is not intended for clinical diagnostic or treatment decisions. Validation on larger cohorts is required before clinical use.","reason":"Pathway prediction computed but not used: Expression data quality insufficient: ['Low gene count (94 < 1000). Pathway prediction may be unreliable.']. Falling back to HRD-based logic."},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"paclitaxel","moa":"taxane chemotherapy","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"adavosertib","moa":"WEE1 inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"ceralasertib","moa":"ATR inhibitor","efficacy_score":0.32,"confidence":0.67,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.67,"capped_confidence":0.67,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"bevacizumab","moa":"anti-VEGF","efficacy_score":0.228,"confidence":0.611,"evidence_tier":"insufficient","badges":["PathwayAligned"],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.54,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.611,"capped_confidence":0.611,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"trametinib","moa":"MEK inhibitor","efficacy_score":0.12,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["CONFIDENCE_CAP_L2"],"efficacy_delta":0.0,"confidence_delta":0.0,"rationale":[{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"},{"name":"pembrolizumab","moa":"anti-PD-1","efficacy_score":0.162,"confidence":0.53,"evidence_tier":"insufficient","badges":[],"evidence_strength":0.0,"citations":[],"citations_count":0,"clinvar":{"classification":null,"review_status":null,"prior":0.0},"evidence_manifest":{"pubmed_query":null,"citations":[],"clinvar":{"classification":null,"review_status":null}},"insights":{"functionality":0.0,"chromatin":0.0,"essentiality":0.0,"regulatory":0.0},"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":0.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"meets_evidence_gate":false,"insufficient_signal":true,"sporadic_gates_provenance":{"germline_status":"positive","level":"L2","gates_applied":["IO_TMB_BOOST","CONFIDENCE_CAP_L2","SPORADIC_SUMMARY"],"efficacy_delta":0.04200000000000001,"confidence_delta":0.0,"rationale":[{"gate":"IO_TMB_BOOST","verdict":"BOOSTED","boost":1.35,"tmb":25.0,"reason":"TMB-high (≥20): 25.0 mut/Mb → Checkpoint inhibitor boost 1.35x"},{"gate":"CONFIDENCE_CAP_L2","verdict":"NO_CAP","cap":null,"level":"L2","completeness":0.85,"original_confidence":0.53,"capped_confidence":0.53,"reason":"Level 2 data (completeness=0.85) → no confidence cap applied"},{"gate":"SPORADIC_SUMMARY","germline_status":"positive","level":"L2","completeness":0.85,"original_efficacy":0.12,"final_efficacy":0.162,"efficacy_delta":0.04200000000000001,"original_confidence":0.53,"final_confidence":0.53,"confidence_delta":0.0,"gates_applied":["IO_TMB_BOOST","CONFIDENCE_CAP_L2"]}]},"label_status":"UNKNOWN","ruo_reasons":["unknown-label","no-citations","low-evidence"],"ruo_reason":"unknown-label","clinical_band":"D (Low/VUS)"}],"pathway_scores":{"tp53":0.4,"ddr":0.01,"immune":0.003,"vegf":0.003,"mapk":null,"pi3k":null,"her2":null,"io":null,"efflux":null},"pathway_scores_meta":{"normalized":true,"defaulted":true,"defaulted_keys":["mapk","pi3k","her2","io","efflux"],"upstream_keys_present":["ddr","efflux","her2","immune","io","mapk","pi3k","tp53","vegf"],"normalization_version":"v1-null-defaults"},"inputs_used":{"mutations":[{"gene":"MBD4","hgvs_p":"p.K431Nfs*54","hgvs_c":"c.1293delA","consequence":"frameshift_variant","classification":"pathogenic","chrom":"3","pos":129433949,"ref":"AT","alt":"A","build":"GRCh38"},{"gene":"PDGFRA","hgvs_p":"p.S755P","hgvs_c":"c.2263T>C","consequence":"missense_variant","classification":"VUS","chrom":"4","pos":54280422,"ref":"T","alt":"C","build":"GRCh38"},{"gene":"TP53","hgvs_p":"p.R273H","hgvs_c":"c.818G>A","consequence":"missense_variant","data_origin":"scenario_inferred","chrom":"17","pos":7673802,"ref":"G","alt":"A"},{"gene":"BRCA1","hgvs_p":"p.E23fs","hgvs_c":"c.68_69delAG","consequence":"frameshift_variant","data_origin":"scenario_inferred","chrom":"17","pos":43044295,"ref":"AG","alt":"-"}],"tumor_context":{"completeness_score":0.85,"somatic_mutations":[{"gene":"TP53","hgvs_p":"p.R273H","consequence":"missense_variant"},{"gene":"BRCA1","hgvs_p":"p.E23fs","consequence":"frameshift_variant"}],"hrd_score":72.0,"hrd_status":"HIGH","tmb":25.0,"tmb_status":"HIGH","msi_status":"MSS","pd_l1_status":"POSITIVE","pd_l1_cps":10,"er_status":"WEAKLY_POSITIVE","er_percent":50,"expression":{"BRCA1":7.8,"BRCA2":7.0,"PALB2":7.2,"RAD51C":6.8,"RAD51D":7.2,"BRIP1":7.2,"BARD1":7.2,"ATM":7.2,"ATR":7.2,"CHEK1":7.2,"CHEK2":7.2,"RAD51":7.2,"RAD52":7.2,"RAD54L":7.2,"FANCA":7.2,"FANCB":7.2,"FANCC":7.2,"FANCD2":7.2,"FANCE":7.2,"FANCF":7.2,"FANCG":7.2,"MRE11A":7.2,"RAD50":7.2,"NBN":7.2,"XRCC2":7.2,"XRCC3":7.2,"PIK3CA":7.8,"PIK3CB":7.8,"PIK3CD":7.8,"PIK3CG":7.8,"PIK3R1":7.8,"PIK3R2":7.8,"PIK3R3":7.8,"AKT1":7.8,"AKT2":7.8,"AKT3":7.8,"PTEN":7.8,"TSC1":7.8,"TSC2":7.8,"MTOR":7.8,"PDK1":7.8,"RPS6KB1":7.8,"RPS6KB2":7.8,"EIF4EBP1":7.8,"RHEB":7.8,"RICTOR":7.8,"RPTOR":7.8,"VEGFA":10.2,"VEGFB":9.0,"VEGFC":8.2,"VEGFD":8.2,"KDR":9.1,"FLT1":8.6,"FLT4":8.2,"ANGPT1":8.8,"ANGPT2":9.2,"TEK":8.5,"TIE1":8.2,"PECAM1":8.2,"VWF":8.2,"ENG":8.2,"KIT":8.2,"PDGFRA":8.2,"PDGFRB":8.2,"KRAS":7.5,"NRAS":7.5,"HRAS":7.5,"BRAF":7.5,"RAF1":7.5,"MAP2K1":7.5,"MAP2K2":7.5,"MAPK1":7.5,"MAPK3":7.5,"NF1":7.5,"RASA1":7.5,"RASA2":7.5,"SPRED1":7.5,"SPRED2":7.5,"ABCB1":8.7,"ABCC1":8.1,"ABCC2":7.6,"ABCC3":7.6,"ABCC4":7.6,"ABCC5":7.6,"ABCC6":7.6,"ABCG2":8.3,"SLC22A1":7.6,"SLC22A2":7.6,"SLC22A3":7.6,"CD274":7.8,"CXCL9":7.2,"GZMB":7.5,"IFNG":7.4,"TNF":7.4},"expression_source":"synthetic_baseline+scenario_overrides","ca125_value":2800.0,"ca125_units":"U/mL","sig7_exposure":0.92}},"provenance":{"run_id":"a5e1bbbe-32c2-4f2c-999c-c21270e55b93","profile":"baseline","cache":"miss","flags":{"fusion_active":false,"evo_use_delta_only":true,"evidence_enabled":true,"confidence_v2":false},"sequence_scoring":{"engine_used":"evo2","true_scoring_required":false,"allow_heuristic_sequence":true,"heuristic_used":false,"variants_sent_to_engine":[{"gene":"PDGFRA","chrom":"4","pos":54280422,"ref":"T","alt":"C","build":"GRCh38","consequence":"missense_variant"},{"gene":"TP53","chrom":"17","pos":7673802,"ref":"G","alt":"A","build":null,"consequence":"missense_variant"}],"variants_excluded":[{"variant":{"gene":"MBD4","chrom":"3","pos":129433949,"ref":"AT","alt":"A"},"reason":"non_snv_requires_normalization"},{"variant":{"gene":"BRCA1","chrom":"17","pos":43044295,"ref":"AG","alt":"-"},"reason":"non_snv_requires_normalization"}],"mode":"evo2_adaptive","count":2},"primary_variant_selection":{"strategy":"max(calibrated_seq_percentile, sequence_disruption)","primary_gene":"TP53","primary_hgvs_p":"p.R273H"},"insights":"skipped_fast_mode","low_confidence_filter":"skipped_by_request_option","confidence_threshold_applied":0.3,"filtered_count":10,"rejected_count":0,"confidence_breakdown":{"top_drug":"olaparib","confidence":0.67,"tier":"insufficient","badges":["PathwayAligned"],"rationale":[{"type":"sequence","value":0.0001,"percentile":0.8},{"type":"pathway","percentile":1.0,"breakdown":{"ras_mapk":0.0,"tp53":0.4}},{"type":"evidence","strength":0.0}],"S_contribution":0.8,"P_contribution":1.0,"E_contribution":0.0,"pathway_disruption":{"tp53":0.4,"ddr":0.01,"immune":0.003,"vegf":0.003}},"lifts":{"ablation_mode":"SPE"},"variant_resolution":{"resolved_count":3,"attempted_count":3,"receipts":[{"gene":"MBD4","hgvs":"MBD4:c.1293delA","ok":true,"receipt":{"ok":true,"status":200,"url":"https://rest.ensembl.org/vep/human/hgvs/MBD4%3Ac.1293delA?content-type=application/json","response":{"assembly":"GRCh38","chrom":"3","pos":129433950,"ref":"T","alt":"-","most_severe_consequence":"frameshift_variant","allele_string":"A/-","normalization":{"needs_left_padding_for_deletion":true,"reference_base":"T","strand_complement_applied":true,"original_ref":"A","original_alt":"-"}}}},{"gene":"MBD4","hgvs":"MBD4:c.1293delA","ok":true,"note":"left_pad_deletion","receipt":{"ok":true,"new_variant":{"chrom":"3","pos":129433949,"ref":"AT","alt":"A","assembly":"GRCh38"},"receipt":{"left_base":{"ok":true,"status":200,"url":"https://rest.ensembl.org/sequence/region/human/3:129433949..129433949?coord_system_version=GRCh38","response":{"seq":"A"}}}}},{"gene":"PDGFRA","hgvs":"PDGFRA:c.2263T>C","ok":true,"receipt":{"ok":true,"status":200,"url":"https://rest.ensembl.org/vep/human/hgvs/PDGFRA%3Ac.2263T%3EC?content-type=application/json","response":{"assembly":"GRCh38","chrom":"4","pos":54280422,"ref":"T","alt":"C","most_severe_consequence":"missense_variant","allele_string":"T/C","normalization":{"needs_left_padding_for_deletion":false,"reference_base":"T"}}}}]}},"completeness":{"level":"L2","level_name":"Good","completeness_score":0.85,"has_germline":true,"has_somatic_ngs":true,"has_ihc":true,"has_hrd":true,"has_tmb":true,"has_expression":true,"has_ca125":true,"missing":[],"confidence_cap":null}}}